Anush Shares and Securities

CLOSE X
Equity 
YOU ARE ON : Home | Equity | Comapny Profile | BOARD MEETINGS
BOARD MEETINGS
Artemis Global Life Sciences Ltd. - (Amalgamated)
BSE CODE: 540616   |   ISIN CODE : INE517U01013
BSE
51.00
0 ( 0% )
 
Prev Close ( Rs.)
51.00
Open ( Rs.)
57.95
 
High ( Rs.)
57.95
Low ( Rs.)
51.00
 
Volume
5234
Week Avg.Volume
1662
 
52 WK High-Low Range
BSE NSE
( )
 
Prev Close ( Rs.)
Open ( Rs.)
 
High ( Rs.)
Low ( Rs.)
 
Volume
Week Avg.Volume
12333
 
52 WK High-Low Range
Source DateBoard Meeting DateDetails
08-Aug-2019 14-Aug-2019 Artemis Global Life Sciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2019 ,inter alia, to consider and approve We wish to inform you that, Pursuant to Regulation 29 and Regulation 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure requirements) Regulations, 2015 a meeting of the Board of Director of the Company is scheduled to be held on 14th August, 2019, inter alia, to consider and approve the standalone and consolidated unaudited financial results of the Company under Indian Accounting Standard (IND AS) for the quarter ended 30 June, 2019. Further in compliance with the Securities and Exchange Board of India (prohibition of Insider Trading) Regulations 2015 and pursuant to the Company's 'Code of Conduct to Regulate, Monitor and Report Trading By Designated Persons', the trading window for dealing in the equity shares of the Company have been closed for the concerned persons, w.e.f. July 1, 2019 and will end 48 hours after results are made public on 14th August, 2019.
25-Apr-2019 08-May-2019 Audited Results
21-Jan-2019 04-Feb-2019 Quarterly Results
30-Oct-2018 12-Nov-2018 Quarterly Results
18-Jul-2018 03-Aug-2018 Quarterly Results
25-Apr-2018 09-May-2018 Sub: Notice of Board Meeting for approval of financial results for the year ending March 31, 2018 and to consider the Restructuring of the Company and its Subsidiaries through a proposed Composite scheme of amalgamation. Dear Sir/ Madam, We, Artemis Global Life Sciences Limited ('Company') wish to inform you that, pursuant to Regulation 29 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015ameeting of the Board of Directors of the Companyis scheduled to be held on 9thMay, 2018, inter alia, to consider and approve the following: (i) Audited financial results (standalone & consolidated) of the Company under Indian Accounting Standards (IND AS) for the quarter/ year ending March 31, 2018. (ii) Restructuring of the Company and its subsidiary companies i.e Artemis Health Sciences Ltd.('AHSL'), Artemis Medicare Services Ltd.('AMSL') and Athena Eduspark Ltd.('AEL')pursuant to a proposed Composite Scheme of Amalgamation between the Company, AHSL, AEL and AMSL and their respective shareholders and creditors under Section 230 to 232 and other applicable provisions of Companies Act, 2013. Further the Company confirms that as per the Company''s Code of Conduct for Prevention of Insider Trading, the trading window for dealing in the securities of the Company would remain closed for the concerned persons that shall commence from 6:00 P.M. on April 25, 2018 and will end 48 hours after the results are made public on May 9, 2018. This is for your information and records. Thanking you Yours truly,
19-Jan-2018 05-Feb-2018 Quarterly Results
16-Oct-2017 31-Oct-2017 Dear Sir/ Madam, We wish to inform you that, Pursuant to Regulation 29 of the Securities and Exchange Board of India (Listing Obligations and Disclosure requirements) Regulations, 2015 a meeting of the Board of Directors of the Company is scheduled to be held on 31st October, 2017 (Tuesday) , inter alia, to consider and approved unaudited financial results of the Company for the quarter/half yearly ended 30th September, 2017. Further the Company Confirms that as per the Company's Code of Conduct for Prevention of Insider Trading, the trading window for dealing in the securities of the Company would remain closed for the concerned persons, that shall commence from 6.00 p.m. on 16th October, 2017 and will end 48 hours after the results are made public on 31st October, 2017. This is for your information and records.
24-Jul-2017 04-Aug-2017 We wish to inform you that, Pursuant to Regulation 29 of the Securities and Exchange Board of India (Listing Obligations and Disclosure requirements) Regulations, 2015 a meeting of the Board of Directors of the Company is scheduled to be held on 4th August, 2017, inter alia, to consider and approved unaudited financial results of the Company for the quarter ended 30th June, 2017. Further the Company Confirms that as per the Company's Code of Conduct for Prevention of Insider Trading, the trading window for dealing in the securities of the Company would remain closed for the concerned persons from July 24, 2017 (Monday) to August 06, 2017 (Sunday) (both days inclusive). The trading window will open on August 07, 2017.
Page 1 of 1
PREV || NEXT
Attention Investors: "Prevent Unauthorized Transactions in your account --> Update your Mobile Numbers/email IDs with your stock brokers. Receive information of your transactions directly from exchange on your mobile/email at the end of the day..... issued in the interest of investors. "
KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account
Prevent Unauthorized Transactions in your demat account:Update your Mobile Number with your Depository Participant. Receive alerts on your Registered Mobile for all debit and other important transactions in your demat account directly from Exchange / CDSL on the same day.........issued in the interest of investors.
SEBI REGN NO: INZ000271235 | DP~IN-DP 672-2022 | Member ID : NSE :14453 | BSE: 6281 | MCX-SX: 11280 |SCM F&O: M50171 | AMFI: 2110
Segregation and Monitoring of Collateral at Client Level with reference to NCL circulars NCL/CMPL/49348 dated August 20, 2021, NCL/CMPL/49640 dated September 17, 2021 and NCL/CMPL/49764 dated September 29, 2021 on the captioned subject
Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 1, 2020.
Update your mobile number & email Id with your stock broker/depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge.
Pay 20% upfront margin of the transaction value to trade in cash market segment.
Investors may please refer to the Exchange's Frequently Asked Questions (FAQs) issued vide circular reference NSE/INSP/45191 dated July 31, 2020 and NSE/INSP/45534 and BSE vide notice no. 20200731-7 dated July 31, 2020 and 20200831-45 dated August 31, 2020 dated August 31, 2020 and other guidelines issued from time to time in this regard 5. Check your Securities /MF/ Bonds in the consolidated account statement issued by NSDL/CDSL every month........... Issued in the interest of Investors. "

BSE
×